Oarsman Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.29M | Buy |
|
|||||
2025
Q1 | $3.69M | Sell |
|
|||||
2024
Q4 | $3.13M | Sell |
|
|||||
2024
Q3 | $3.77M | Buy |
|
|||||
2024
Q2 | $3.22M | Buy |
|
|||||
2024
Q1 | $3.2M | Sell |
|
|||||
2023
Q4 | $3.61M | Buy |
|
|||||
2023
Q3 | $3.35M | Buy |
|
|||||
2023
Q2 | $3.01M | Sell |
|
|||||
2023
Q1 | $3.89M | Buy |
|
|||||
2022
Q4 | $3.87M | Sell |
|
|||||
2022
Q3 | $3.31M | Buy |
|
|||||
2022
Q2 | $3.77M | Sell |
|
|||||
2022
Q1 | $4.36M | Sell |
|
|||||
2021
Q4 | $3.85M | Sell |
|
|||||
2021
Q3 | $3.29M | Sell |
|
|||||
2021
Q2 | $3.43M | Sell |
|
|||||
2021
Q1 | $3.45M | Sell |
|
|||||
2020
Q4 | $3.95M | Sell |
|
|||||
2020
Q3 | $3.43M | Sell |
|
|||||
2020
Q2 | $3.94M | Buy |
|
|||||
2020
Q1 | $1.57M | Sell |
|
|||||
2019
Q4 | $3.25M | Buy |
|
|||||
2019
Q3 | $2.63M | Buy |
|
|||||
2019
Q2 | $2.39M | Sell |
|
|||||
2019
Q1 | $2.65M | Sell |
|
|||||
2018
Q4 | $4.24M | Buy |
|
|||||
2018
Q3 | $4.24M | Buy |
|
|||||
2018
Q2 | $4.14M | Buy |
|
|||||
2018
Q1 | $4.08M | Sell |
|
|||||
2017
Q4 | $4.29M | Sell |
|
|||||
2017
Q3 | $3.97M | Buy |
|
|||||
2017
Q2 | $3.13M | Buy |
|
|||||
2017
Q1 | $2.74M | Buy |
|
|||||
2016
Q4 | $2.31M | Sell |
|
|||||
2016
Q3 | $2.57M | Buy |
|
|||||
2016
Q2 | $2.49M | Buy |
|
|||||
2016
Q1 | $2.23M | Buy |
|
|||||
2015
Q4 | $1.5M | Buy |
|
|||||
2015
Q3 | $1.36M | Buy |
|
|||||
2015
Q2 | $1.68M | Buy |
|
|||||
2015
Q1 | $1.44M | Sell |
|
|||||
2014
Q4 | $1.61M | Sell |
|
|||||
2014
Q3 | $1.44M | Buy |
|
|||||
2014
Q2 | $1.37M | Buy |
|
|||||
2014
Q1 | $1.16M | Buy |
|
|||||
2013
Q4 | $1.19M | Buy |
|
|||||
2013
Q3 | $1.01M | Buy |
|
|||||
2013
Q2 | $897K | Buy |
|